Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB173914

G-CSFR/CD114 Antibody (38660), DyLight 755, Novus Biologicals™
SDP

Catalog No. NB173914 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.5 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB173914 0.5 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. NB173914 Supplier Novus Biologicals Supplier No. FAB381Z
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

G-CSFR/CD114 Monoclonal antibody specifically detects G-CSFR/CD114 in Human samples. It is validated for Western Blot, Flow Cytometry

Specifications

Antigen G-CSFR/CD114
Applications Western Blot, Flow Cytometry
Classification Monoclonal
Clone 38660
Conjugate DyLight 755
Formulation 50mM Sodium Borate
Gene Alias CD114, CD114 antigen, colony stimulating factor 3 receptor (granulocyte), G-CSF receptor, GCSFRG-CSF-R, granulocyte colony-stimulating factor receptor
Host Species Mouse
Immunogen Mouse myeloma cell line NS0-derived recombinant human G-CSF R/CD114, Glu25-Pro621, Accession # Q99062
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.5 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 1441
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.